Gudas LJ - Search Results

1

Validation of risk factors for recurrence of renal cell carcinoma: Results from a large single-institution series.

van der Mijn JC, Al Hussein Al Awamlh B, Islam Khan A, Posada-Calderon L, Oromendia C, Fainberg J, Alshak M, Elahjji R, Pierce H, Taylor B, Gudas LJ, Nanus DM, Molina AM, Del Pizzo J, Scherr DS. van der Mijn JC, et al. Among authors: gudas lj. PLoS One. 2019 Dec 9;14(12):e0226285. doi: 10.1371/journal.pone.0226285. eCollection 2019. PLoS One. 2019. PMID: 31815952 Free PMC article.

2

Reduced levels of retinyl esters and vitamin A in human renal cancers.

Guo X, Nanus DM, Ruiz A, Rando RR, Bok D, Gudas LJ. Guo X, et al. Among authors: gudas lj. Cancer Res. 2001 Mar 15;61(6):2774-81. Cancer Res. 2001. PMID: 11289161

3

Retinol metabolism and lecithin:retinol acyltransferase levels are reduced in cultured human prostate cancer cells and tissue specimens.

Guo X, Knudsen BS, Peehl DM, Ruiz A, Bok D, Rando RR, Rhim JS, Nanus DM, Gudas LJ. Guo X, et al. Among authors: gudas lj. Cancer Res. 2002 Mar 15;62(6):1654-61. Cancer Res. 2002. PMID: 11912136

4

Phase I trial of interferon alpha2b and liposome-encapsulated all-trans retinoic acid in the treatment of patients with advanced renal cell carcinoma.

Goldberg JS, Vargas M, Rosmarin AS, Milowsky MI, Papanicoloau N, Gudas LJ, Shelton G, Feit K, Petrylak D, Nanus DM. Goldberg JS, et al. Among authors: gudas lj. Cancer. 2002 Sep 15;95(6):1220-7. doi: 10.1002/cncr.10809. Cancer. 2002. PMID: 12216088 Free article. Clinical Trial.

5

Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney.

Zhan HC, Gudas LJ, Bok D, Rando R, Nanus DM, Tickoo SK. Zhan HC, et al. Among authors: gudas lj. Clin Cancer Res. 2003 Oct 15;9(13):4897-905. Clin Cancer Res. 2003. PMID: 14581364

6

Reduced lecithin: retinol acyltransferase expression correlates with increased pathologic tumor stage in bladder cancer.

Boorjian S, Tickoo SK, Mongan NP, Yu H, Bok D, Rando RR, Nanus DM, Scherr DS, Gudas LJ. Boorjian S, et al. Among authors: gudas lj. Clin Cancer Res. 2004 May 15;10(10):3429-37. doi: 10.1158/1078-0432.CCR-03-0756. Clin Cancer Res. 2004. PMID: 15161698

7

Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer.

Boorjian S, Ugras S, Mongan NP, Gudas LJ, You X, Tickoo SK, Scherr DS. Boorjian S, et al. Among authors: gudas lj. Urology. 2004 Aug;64(2):383-8. doi: 10.1016/j.urology.2004.03.025. Urology. 2004. PMID: 15302512

8

Retinoid receptor mRNA expression profiles in human bladder cancer specimens.

Boorjian S, Scherr DS, Mongan NP, Zhuang Y, Nanus DM, Gudas LJ. Boorjian S, et al. Among authors: gudas lj. Int J Oncol. 2005 Apr;26(4):1041-8. Int J Oncol. 2005. PMID: 15754000

9

Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.

Touma SE, Goldberg JS, Moench P, Guo X, Tickoo SK, Gudas LJ, Nanus DM. Touma SE, et al. Among authors: gudas lj. Clin Cancer Res. 2005 May 1;11(9):3558-66. doi: 10.1158/1078-0432.CCR-04-1155. Clin Cancer Res. 2005. PMID: 15867260

10

Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma.

Raman JD, Mongan NP, Liu L, Tickoo SK, Nanus DM, Scherr DS, Gudas LJ. Raman JD, et al. Among authors: gudas lj. Carcinogenesis. 2006 Mar;27(3):499-507. doi: 10.1093/carcin/bgi299. Epub 2005 Dec 12. Carcinogenesis. 2006. PMID: 16344273

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

285 results

Search Page

Filters